Condensed Consolidating Financial Information

12 Months Ended

Dec. 31, 2019

Condensed Financial Information Disclosure [Abstract]

Condensed Consolidating Financial Information

Condensed Consolidating Financial Information:

The accompanying condensed consolidating financial information has been prepared and presented pursuant to SEC Regulation S-X, Rule 3-10, “Financial Statements of Guarantors and Issuers of Guaranteed Securities Registered or Being Registered.” Each of the subsidiary guarantors is 100% owned by Encompass Health, and all guarantees are full and unconditional and joint and several, subject to certain customary conditions for release. Encompass Health’s investments in its consolidated subsidiaries, as well as guarantor subsidiaries’ investments in nonguarantor subsidiaries and nonguarantor subsidiaries’ investments in guarantor subsidiaries, are presented under the equity method of accounting with the related investment presented within the line items Intercompany receivable and Intercompany payable in the accompanying condensed consolidating balance sheets.

The terms of our credit agreement allow us to declare and pay cash dividends on our common stock so long as: (1) we are not in default under our credit agreement and (2) our senior secured leverage ratio (as defined in our credit agreement) remains less than or equal to 2x. The terms of our senior note indenture allow us to declare and pay cash dividends on our common stock so long as (1) we are not in default, (2) the consolidated coverage ratio (as defined in the indenture) exceeds 2x or we are otherwise allowed under the indenture to incur debt, and (3) we have capacity under the indenture’s restricted payments covenant to declare and pay dividends. See Note 10, Long-term Debt.

Periodically, certain wholly owned subsidiaries of Encompass Health make dividends or distributions of available cash and/or intercompany receivable balances to their parents. In addition, Encompass Health makes contributions to certain wholly owned subsidiaries. When made, these dividends, distributions, and contributions impact the Intercompany receivable, Intercompany payable, and Encompass Health shareholders’ equity line items in the accompanying condensed consolidating balance sheet but have no impact on the consolidated financial statements of Encompass Health Corporation.

The “Holdings” column in the condensed consolidating financial statements below represents Holdings and its wholly-owned subsidiaries. As discussed in Note 12, Redeemable Noncontrolling Interests, Holdings had 5.5% noncontrolling interest as of December 31, 2019, and accordingly, Holdings and its wholly-owned subsidiaries were not guarantors of our debt. In February 2020, we acquired for cash all but 1.2% of the remaining noncontrolling interest in Holdings following the most recent exercise of the put option by the management investors. On February 20, 2020, Encompass Health Corporation and each of the two remaining management investors agreed to exchange the remaining shares representing the noncontrolling interest for an equal value of shares of common stock of Encompass Health Corporation. We expect to settle the exchanges in March 2020.




	For the Year Ended December 31, 2019
	Encompass Health Corporation			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Holdings			Eliminating Entries			Encompass Health Consolidated
	(In Millions)
Net operating revenues	$	20.7		$	2,425.5		$	1,221.7		$	1,074.1		$	(137.0	)	$	4,605.0
Operating expenses:
Salaries and benefits	59.6			1,176.5			608.7			748.9			(20.7		)	2,573.0
Other operating expenses	45.0			351.8			189.3			88.4			(50.9		)	623.6
Occupancy costs	2.1			100.8			27.5			17.3			(65.4		)	82.3
Supplies	—			98.0			49.3			20.6			—			167.9
General and administrative expenses	160.0			—			—			87.0			—			247.0
Depreciation and amortization	19.9			106.8			54.9			37.1			—			218.7
Total operating expenses	286.6			1,833.9			929.7			999.3			(137.0		)	3,912.5
Loss on early extinguishment of debt	7.7			—			—			—			—			7.7
Interest expense and amortization of debt discounts and fees	131.0			24.7			5.6			28.4			(30.0		)	159.7
Other income	(32.3		)	(21.1		)	(7.1		)	—			30.0			(30.5		)
Equity in net income of nonconsolidated affiliates	—			(5.1		)	(0.4		)	(1.2		)	—			(6.7		)
Equity in net income of consolidated affiliates	(492.6		)	(67.0		)	—			—			559.6			—
Management fees	(160.8		)	117.8			43.0			—			—			—
Income from continuing operations before income tax (benefit) expense	281.1			542.3			250.9			47.6			(559.6		)	562.3
Provision for income tax (benefit) expense	(78.2		)	140.3			40.3			13.5			—			115.9
Income from continuing operations	359.3			402.0			210.6			34.1			(559.6		)	446.4
Loss from discontinued operations, net of tax	(0.6		)	—			—			—			—			(0.6		)
Net income	358.7			402.0			210.6			34.1			(559.6		)	445.8
Less: Net income attributable to noncontrolling interests	—			—			(83.3		)	(3.8		)	—			(87.1		)
Net income attributable to Encompass Health	$	358.7		$	402.0		$	127.3		$	30.3		$	(559.6	)	$	358.7
Comprehensive income	$	358.7		$	402.0		$	210.6		$	34.1		$	(559.6	)	$	445.8
Comprehensive income attributable to Encompass Health	$	358.7		$	402.0		$	127.3		$	30.3		$	(559.6	)	$	358.7




	For the Year Ended December 31, 2018
	Encompass Health Corporation			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Holdings			Eliminating Entries			Encompass Health Consolidated
	(In Millions)
Net operating revenues	$	21.0		$	2,351.8		$	1,118.9		$	915.9		$	(130.3	)	$	4,277.3
Operating expenses:
Salaries and benefits	49.5			1,132.2			550.4			643.3			(21.4		)	2,354.0
Other operating expenses	37.9			344.3			177.4			75.3			(49.8		)	585.1
Occupancy costs	1.9			95.7			25.4			14.1			(59.1		)	78.0
Supplies	—			95.8			44.9			18.0			—			158.7
General and administrative expenses	161.0			—			—			59.2			—			220.2
Depreciation and amortization	14.3			108.2			47.6			29.6			—			199.7
Government, class action, and related settlements	52.0			—			—			—			—			52.0
Total operating expenses	316.6			1,776.2			845.7			839.5			(130.3		)	3,647.7
Interest expense and amortization of debt discounts and fees	124.2			22.6			2.2			23.5			(25.2		)	147.3
Other income	(22.4		)	(1.0		)	(3.5		)	(0.5		)	25.2			(2.2		)
Equity in net income of nonconsolidated affiliates	—			(7.1		)	(0.4		)	(1.2		)	—			(8.7		)
Equity in net income of consolidated affiliates	(465.6		)	(63.4		)	—			—			529.0			—
Management fees	(153.1		)	114.0			39.1			—			—			—
Income from continuing operations before income tax (benefit) expense	221.3			510.5			235.8			54.6			(529.0		)	493.2
Provision for income tax (benefit) expense	(69.9		)	136.6			38.4			13.8			—			118.9
Income from continuing operations	291.2			373.9			197.4			40.8			(529.0		)	374.3
Income from discontinued operations, net of tax	1.1			—			—			—			—			1.1
Net income	292.3			373.9			197.4			40.8			(529.0		)	375.4
Less: Net income attributable to noncontrolling interests	—			—			(77.8		)	(5.3		)	—			(83.1		)
Net income attributable to Encompass Health	$	292.3		$	373.9		$	119.6		$	35.5		$	(529.0	)	$	292.3
Comprehensive income	$	292.3		$	373.9		$	197.4		$	40.8		$	(529.0	)	$	375.4
Comprehensive income attributable to Encompass Health	$	292.3		$	373.9		$	119.6		$	35.5		$	(529.0	)	$	292.3




	For the Year Ended December 31, 2017
	Encompass Health Corporation			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Holdings			Eliminating Entries			Encompass Health Consolidated
	(In Millions)
Net operating revenues	$	21.3		$	2,252.5		$	1,006.4		$	759.8		$	(126.1	)	$	3,913.9
Operating expenses:
Salaries and benefits	34.7			1,088.7			508.9			543.3			(21.0		)	2,154.6
Other operating expenses	32.8			324.8			160.2			62.4			(48.6		)	531.6
Occupancy costs	1.9			93.7			23.0			11.4			(56.5		)	73.5
Supplies	—			94.2			41.7			13.4			—			149.3
General and administrative	143.7			—			—			28.0			—			171.7
Depreciation and amortization	8.8			106.6			44.7			23.7			—			183.8
Total operating expenses	221.9			1,708.0			778.5			682.2			(126.1		)	3,264.5
Loss on early extinguishment of debt	10.7			—			—			—			—			10.7
Interest expense and amortization of debt discounts and fees	130.5			23.2			2.5			19.2			(21.0		)	154.4
Other (income) loss	(21.7		)	0.2			(3.6		)	—			21.0			(4.1		)
Equity in net income of nonconsolidated affiliates	—			(6.9		)	(0.4		)	(0.7		)	—			(8.0		)
Equity in net income of consolidated affiliates	(342.1		)	(39.0		)	—			—			381.1			—
Management fees	(145.0		)	109.5			35.5			—			—			—
Income from continuing operations before income tax (benefit) expense	167.0			457.5			193.9			59.1			(381.1		)	496.4
Provision for income tax (benefit) expense	(104.5		)	182.6			66.8			0.9			—			145.8
Income from continuing operations	271.5			274.9			127.1			58.2			(381.1		)	350.6
Loss from discontinued operations, net of tax	(0.4		)	—			—			—			—			(0.4		)
Net income	271.1			274.9			127.1			58.2			(381.1		)	350.2
Less: Net income attributable to noncontrolling interests	—			—			(68.7		)	(10.4		)	—			(79.1		)
Net income attributable to Encompass Health	$	271.1		$	274.9		$	58.4		$	47.8		$	(381.1	)	$	271.1
Comprehensive income	$	271.0		$	274.9		$	127.1		$	58.2		$	(381.1	)	$	350.1
Comprehensive income attributable to Encompass Health	$	271.0		$	274.9		$	58.4		$	47.8		$	(381.1	)	$	271.0




	As of December 31, 2019
	Encompass Health Corporation		Guarantor Subsidiaries		Non-guarantor Subsidiaries		Holdings		Eliminating Entries			Encompass Health Consolidated
	(In Millions)
Assets
Current assets:
Cash and cash equivalents	$	53.7	$	5.2	$	6.0	$	29.9	$	—		$	94.8
Restricted cash	—		—		57.4		—		—			57.4
Accounts receivable	—		280.4		125.6		100.1		—			506.1
Prepaid expenses and other current assets	64.3		35.4		9.3		7.8		(19.3		)	97.5
Total current assets	118.0		321.0		198.3		137.8		(19.3		)	755.8
Property and equipment, net	133.4		1,246.0		551.2		28.7		—			1,959.3
Operating lease right-of-use assets	10.1		171.5		86.5		43.7		(35.3		)	276.5
Goodwill	—		912.2		323.0		1,070.0		—			2,305.2
Intangible assets, net	17.7		101.7		65.3		291.6		—			476.3
Deferred income tax assets	27.2		11.1		0.1		—		(35.5		)	2.9
Other long-term assets	53.6		85.4		151.6		14.1		—			304.7
Intercompany notes receivable	737.8		—		—		—		(737.8		)	—
Intercompany receivable and investments in consolidated affiliates	3,155.4		523.6		—		—		(3,679.0		)	—
Total assets	$	4,253.2	$	3,372.5	$	1,376.0	$	1,585.9	$	(4,506.9	)	$	6,080.7
Liabilities and Shareholders’ Equity
Current liabilities:
Current portion of long-term debt	$	17.0	$	10.4	$	3.8	$	8.1	$	—		$	39.3
Current operating lease liabilities	1.3		21.9		16.0		12.1		(10.9		)	40.4
Accounts payable	9.8		56.5		24.3		4.0		—			94.6
Accrued payroll	34.8		76.2		40.4		59.1		—			210.5
Accrued interest payable	30.4		2.0		—		—		—			32.4
Other current liabilities	82.2		30.5		68.8		141.6		(19.3		)	303.8
Total current liabilities	175.5		197.5		153.3		224.9		(30.2		)	721.0
Long-term debt, net of current portion	2,670.6		305.4		41.6		5.7		—			3,023.3
Long-term operating lease liabilities	9.0		153.9		73.6		31.9		(24.6		)	243.8
Intercompany notes payable	—		—		—		737.8		(737.8		)	—
Self-insured risks	19.3		—		97.9		—		—			117.2
Other long-term liabilities	26.6		12.2		2.4		37.0		(35.5		)	42.7
Intercompany payable	—		—		66.0		4.4		(70.4		)	—
	2,901.0		669.0		434.8		1,041.7		(898.5		)	4,148.0
Commitments and contingencies
Redeemable noncontrolling interests	—		—		31.4		208.2		—			239.6
Shareholders’ equity:
Encompass Health shareholders’ equity	1,352.2		2,703.5		568.9		336.0		(3,608.4		)	1,352.2
Noncontrolling interests	—		—		340.9		—		—			340.9
Total shareholders’ equity	1,352.2		2,703.5		909.8		336.0		(3,608.4		)	1,693.1
Total liabilities and shareholders’ equity	$	4,253.2	$	3,372.5	$	1,376.0	$	1,585.9	$	(4,506.9	)	$	6,080.7




	As of December 31, 2018
	Encompass Health Corporation		Guarantor Subsidiaries		Non-guarantor Subsidiaries		Holdings		Eliminating Entries			Encompass Health Consolidated
	(In Millions)
Assets
Current assets:
Cash and cash equivalents	$	41.5	$	3.0	$	5.1	$	19.6	$	—		$	69.2
Restricted cash	—		—		59.0		—		—			59.0
Accounts receivable	—		270.7		121.6		75.4		—			467.7
Prepaid expenses and other current assets	36.3		17.6		26.2		4.9		(18.8		)	66.2
Total current assets	77.8		291.3		211.9		99.9		(18.8		)	662.1
Property and equipment, net	123.9		1,041.5		445.2		24.2		—			1,634.8
Goodwill	—		912.2		293.3		895.3		—			2,100.8
Intangible assets, net	21.4		96.6		67.5		257.9		—			443.4
Deferred income tax assets	47.9		28.9		0.1		—		(34.0		)	42.9
Other long-term assets	47.9		100.4		130.9		11.8		—			291.0
Intercompany notes receivable	535.3		—		—		—		(535.3		)	—
Intercompany receivable and investments in consolidated affiliates	2,904.4		457.6		—		—		(3,362.0		)	—
Total assets	$	3,758.6	$	2,928.5	$	1,148.9	$	1,289.1	$	(3,950.1	)	$	5,175.0
Liabilities and Shareholders’ Equity
Current liabilities:
Current portion of long-term debt	$	35.0	$	7.5	$	4.4	$	6.4	$	(17.5	)	$	35.8
Accounts payable	8.9		46.4		30.4		4.3		—			90.0
Accrued payroll	35.0		69.1		35.4		48.9		—			188.4
Accrued interest payable	22.3		2.4		—		—		(0.3		)	24.4
Other current liabilities	154.5		5.1		85.7		89.6		(1.0		)	333.9
Total current liabilities	255.7		130.5		155.9		149.2		(18.8		)	672.5
Long-term debt, net of current portion	2,188.7		262.1		20.0		7.8		—			2,478.6
Intercompany notes payable	—		—		—		535.3		(535.3		)	—
Self-insured risks	16.1		—		103.5		—		—			119.6
Other long-term liabilities	21.4		17.1		5.0		76.0		(33.9		)	85.6
Intercompany payable	—		—		48.9		4.2		(53.1		)	—
	2,481.9		409.7		333.3		772.5		(641.1		)	3,356.3
Commitments and contingencies
Redeemable noncontrolling interests	—		—		38.3		223.4		—			261.7
Shareholders’ equity
Encompass Health shareholders’ equity	1,276.7		2,518.8		497.0		293.2		(3,309.0		)	1,276.7
Noncontrolling interests	—		—		280.3		—		—			280.3
Total shareholders’ equity	1,276.7		2,518.8		777.3		293.2		(3,309.0		)	1,557.0
Total liabilities and shareholders’ equity	$	3,758.6	$	2,928.5	$	1,148.9	$	1,289.1	$	(3,950.1	)	$	5,175.0



	For the Year Ended December 31, 2019
	Encompass Health Corporation			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Holdings			Eliminating Entries			Encompass Health Consolidated
	(In Millions)
Net cash (used in) provided by operating activities	$	(110.8	)	$	450.3		$	247.9		$	47.9		$	—		$	635.3
Cash flows from investing activities:
Acquisition of businesses, net of cash acquired	(217.8		)	—			—			(13.7		)	—			(231.5		)
Purchases of property and equipment	(38.6		)	(207.3		)	(117.9		)	(8.6		)	—			(372.4		)
Additions to capitalized software costs	(7.4		)	(0.7		)	(1.4		)	(3.5		)	—			(13.0		)
Purchases of intangible assets	—			(18.0		)	—			(0.7		)	—			(18.7		)
Proceeds from sale of restricted investments	—			—			17.6			—			—			17.6
Purchases of restricted investments	—			—			(30.9		)	(2.0		)	—			(32.9		)
Funding of intercompany note receivable	(64.0		)	—			—			—			64.0			—
Proceeds from repayment of intercompany note receivable	93.0			—			17.5			—			(110.5		)	—
Other, net	(8.3		)	8.2			(6.7		)	0.3			—			(6.5		)
Net cash provided used in investing activities	(243.1		)	(217.8		)	(121.8		)	(28.2		)	(46.5		)	(657.4		)
Cash flows from financing activities:
Proceeds from bond issuance	1,000.0			—			—			—			—			1,000.0
Principal payments on debt, including pre-payments	(517.8		)	—			(1.7		)	—			—			(519.5		)
Principal borrowings on intercompany note payable	—			—			—			64.0			(64.0		)	—
Principal payments on intercompany note payable	(17.5		)	—			—			(93.0		)	110.5			—
Borrowings on revolving credit facility	635.0			—			—			—			—			635.0
Payments on revolving credit facility	(620.0		)	—			—			—			—			(620.0		)
Principal payments under finance lease obligations	(0.7		)	(8.3		)	(2.6		)	(7.9		)	—			(19.5		)
Debt amendment and issuance costs	(21.5		)	—			—			—			—			(21.5		)
Repurchases of common stock, including fees and expenses	(45.9		)	—			—			—			—			(45.9		)
Dividends paid on common stock	(108.6		)	—			—			(0.1		)	—			(108.7		)
Purchase of equity interests in consolidated affiliates	(162.9		)	—			—			—			—			(162.9		)
Distributions paid to noncontrolling interests of consolidated affiliates	—			—			(79.8		)	—			—			(79.8		)
Taxes paid on behalf of employees for shares withheld	(15.4		)	—			—			(1.2		)	—			(16.6		)
Contributions from consolidated affiliates	—			—			15.9			—			—			15.9
Other, net	(4.4		)	—			—			(3.9		)	—			(8.3		)
Change in intercompany advances	245.8			(222.0		)	(56.5		)	32.7			—			—
Net cash provided by (used in) financing activities	366.1			(230.3		)	(124.7		)	(9.4		)	46.5			48.2
Increase in cash, cash equivalents, and restricted cash	12.2			2.2			1.4			10.3			—			26.1
Cash, cash equivalents, and restricted cash at beginning of year	41.5			3.0			69.4			19.6			—			133.5
Cash, cash equivalents and restricted cash at end of year	$	53.7		$	5.2		$	70.8		$	29.9		$	—		$	159.6

Reconciliation of Cash, Cash Equivalents, and Restricted Cash
Cash and cash equivalents at beginning of period	$	41.5		$	3.0		$	5.1		$	19.6		$	—		$	69.2
Restricted cash at beginning of period	—			—			59.0			—			—			59.0
Restricted cash included in other long-term assets at beginning of period	—			—			5.3			—			—			5.3
Cash, cash equivalents, and restricted cash at beginning of period	$	41.5		$	3.0		$	69.4		$	19.6		$	—		$	133.5

Cash and cash equivalents at end of period	$	53.7		$	5.2		$	6.0		$	29.9		$	—		$	94.8
Restricted cash at end of period	—			—			57.4			—			—			57.4
Restricted cash included in other long-term assets at end of period	—			—			7.4			—			—			7.4
Cash, cash equivalents, and restricted cash at end of period	$	53.7		$	5.2		$	70.8		$	29.9		$	—		$	159.6

Supplemental schedule of noncash financing activity:
Intercompany note activity	$	(232.9	)	$	—		$	—		$	232.9		$	—		$	—



	For the Year Ended December 31, 2018
	Encompass Health Corporation			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Holdings			Eliminating Entries			Encompass Health Consolidated
	(In Millions)
Net cash (used in) provided by operating activities	$	(11.3	)	$	422.2		$	259.0		$	92.5		$	—		$	762.4
Cash flows from investing activities:
Acquisition of businesses, net of cash acquired	(131.4		)	—			—			(12.5		)	—			(143.9		)
Purchases of property and equipment	(34.1		)	(133.9		)	(79.9		)	(6.6		)	—			(254.5		)
Additions to capitalized software costs	(14.1		)	(0.1		)	—			(1.8		)	—			(16.0		)
Purchases of intangible assets	(2.5		)	—			(0.1		)	(3.1		)	—			(5.7		)
Proceeds from sale of restricted investments	—			—			11.6			—			—			11.6
Purchases of restricted investments	—			—			(13.3		)	—			—			(13.3		)
Proceeds from repayment of intercompany note receivable	87.0			—			—			—			(87.0		)	—
Other, net	(6.0		)	2.8			—			0.5			—			(2.7		)
Net cash used in investing activities	(101.1		)	(131.2		)	(81.7		)	(23.5		)	(87.0		)	(424.5		)
Cash flows from financing activities:
Principal payments on debt, including pre-payments	(17.6		)	—			(3.0		)	—			—			(20.6		)
Principal payments on intercompany notes payable	—			—			—			(87.0		)	87.0			—
Borrowings on revolving credit facility	325.0			—			—			—			—			325.0
Payments on revolving credit facility	(390.0		)	—			—			—			—			(390.0		)
Principal payments under finance lease obligations	—			(8.4		)	(4.2		)	(5.3		)	—			(17.9		)
Debt amendment and issuance costs	—			—			(0.1		)	—			—			(0.1		)
Dividends paid on common stock	(100.7		)	—			—			(0.1		)	—			(100.8		)
Purchase of equity interests in consolidated affiliates	(65.1		)	—			—			—			—			(65.1		)
Distributions paid to noncontrolling interests of consolidated affiliates	—			—			(75.4		)	—			—			(75.4		)
Taxes paid on behalf of employees for shares withheld	(7.4		)	—			—			(0.9		)	—			(8.3		)
Contributions from consolidated affiliates	—			—			12.6			—			—			12.6
Other, net	3.0			—			13.2			3.2			—			19.4
Change in intercompany advances	372.4			(282.5		)	(118.9		)	29.0			—			—
Net cash provided by (used in) financing activities	119.6			(290.9		)	(175.8		)	(61.1		)	87.0			(321.2		)
Increase in cash, cash equivalents, and restricted cash	7.2			0.1			1.5			7.9			—			16.7
Cash, cash equivalents, and restricted cash at beginning of year	34.3			2.9			67.9			11.7			—			116.8
Cash, cash equivalents, and restricted cash at end of year	$	41.5		$	3.0		$	69.4		$	19.6		$	—		$	133.5

Reconciliation of Cash, Cash Equivalents, and Restricted Cash
Cash and cash equivalents at beginning of period	$	34.3		$	2.9		$	5.5		$	11.7		$	—		$	54.4
Restricted cash at beginning of period	—			—			62.4			—			—			62.4
Cash, cash equivalents, and restricted cash at beginning of period	$	34.3		$	2.9		$	67.9		$	11.7		$	—		$	116.8

Cash and cash equivalents at end of period	$	41.5		$	3.0		$	5.1		$	19.6		$	—		$	69.2
Restricted cash at end of period	—			—			59.0			—			—			59.0
Restricted cash included in other long-term assets at end of period	—			—			5.3			—			—			5.3
Cash, cash equivalents, and restricted cash at end of period	$	41.5		$	3.0		$	69.4		$	19.6		$	—		$	133.5

Supplemental schedule of noncash investing activities:
Intercompany note activity	$	(136.8	)	$	—		$	—		$	136.8		$	—		$	—



	For the Year Ended December 31, 2017
	Encompass Health Corporation			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Holdings			Eliminating Entries			Encompass Health Consolidated
	(In Millions)
Net cash provided by operating activities	$	28.2		$	385.9		$	181.2		$	63.0		$	—		$	658.3
Cash flows from investing activities:
Acquisition of businesses, net of cash acquired	(10.9		)	—			—			(27.9		)	—			(38.8		)
Purchases of property and equipment	(39.4		)	(106.5		)	(75.4		)	(4.5		)	—			(225.8		)
Additions to capitalized software costs	(16.3		)	(0.3		)	(0.1		)	(2.5		)	—			(19.2		)
Purchases of intangible assets	—			—			—			(3.7		)	—			(3.7		)
Proceeds from sale of restricted investments	—			—			4.2			—			—			4.2
Purchases of restricted investments	—			—			(8.5		)	—			—			(8.5		)
Proceeds from repayment of intercompany note receivable	51.0			—			—			—			(51.0		)	—
Other, net	(3.7		)	11.7			0.2			0.6			—			8.8
Net cash used in investing activities	(19.3		)	(95.1		)	(79.6		)	(38.0		)	(51.0		)	(283.0		)
Cash flows from financing activities:
Principal payments on debt, including pre-payments	(126.9		)	—			(3.0		)	—			—			(129.9		)
Principal payments on intercompany notes payable	—			—			—			(51.0		)	51.0			—
Borrowings on revolving credit facility	273.3			—			—			—			—			273.3
Payments on revolving credit facility	(330.3		)	—			—			—			—			(330.3		)
Principal payments under finance lease obligations	—			(7.3		)	(3.9		)	(4.1		)	—			(15.3		)
Debt amendment and issuance costs	(4.1		)	—			—			—			—			(4.1		)
Repurchases of common stock, including fees and expenses	(38.1		)	—			—			—			—			(38.1		)
Dividends paid on common stock	(91.5		)	—			—			—			—			(91.5		)
Proceeds from exercising stock warrants	26.6			—			—			—			—			26.6
Distributions paid to noncontrolling interests of consolidated affiliates	—			—			(51.9		)	—			—			(51.9		)
Taxes paid on behalf of employees for shares withheld	(19.5		)	—			—			(0.3		)	—			(19.8		)
Contributions from consolidated affiliates	—			—			20.8			—			—			20.8
Other, net	1.0			—			—			(0.7		)	—			0.3
Change in intercompany advances	314.3			(282.2		)	(62.0		)	29.9			—			—
Net cash provided by (used in) financing activities	4.8			(289.5		)	(100.0		)	(26.2		)	51.0			(359.9		)
Increase in cash, cash equivalents, and restricted cash	13.7			1.3			1.6			(1.2		)	—			15.4
Cash, cash equivalents, and restricted cash at beginning of year	20.6			1.6			66.3			12.9			—			101.4
Cash, cash equivalents, and restricted cash at end of year	$	34.3		$	2.9		$	67.9		$	11.7		$	—		$	116.8

Reconciliation of Cash, Cash Equivalents, and Restricted Cash
Cash and cash equivalents at beginning of period	$	20.6		$	1.6		$	5.4		$	12.9		$	—		$	40.5
Restricted cash at beginning of period	—			—			60.9			—			—			60.9
Cash, cash equivalents, and restricted cash at beginning of period	$	20.6		$	1.6		$	66.3		$	12.9		$	—		$	101.4

Cash and cash equivalents at end of period	$	34.3		$	2.9		$	5.5		$	11.7		$	—		$	54.4
Restricted cash at end of period	—			—			62.4			—			—			62.4
Cash, cash equivalents, and restricted cash at end of period	$	34.3		$	2.9		$	67.9		$	11.7		$	—		$	116.8

Supplemental schedule of noncash financing activities:
Intercompany note activity	$	(8.8	)	$	—		$	—		$	8.8		$	—		$	—
Conversion of convertible debt	319.4			—			—			—			—			319.4